{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T13:00:04Z","timestamp":1769950804816,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.ijtb.2023.01.006","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T15:55:38Z","timestamp":1673884538000},"page":"S10-S14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S1","title":["Drug resistance patterns and treatment outcomes in DR-TB patients at a tertiary care centre in Mumbai"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-1037","authenticated-orcid":false,"given":"Sanchit","family":"Mohan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishwanath","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priti","family":"Meshram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2023.01.006_bib1","series-title":"Global Tuberculosis Report 2019","year":"2019"},{"key":"10.1016\/j.ijtb.2023.01.006_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147529","article-title":"Pattern of drug resistance and risk factors associated with development of drug resistant Mycobacterium tuberculosis in Pakistan","volume":"11","author":"Ullah","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2023.01.006_bib3","series-title":"National Anti-TB Drug Resistance","year":"2018"},{"key":"10.1016\/j.ijtb.2023.01.006_bib4","first-page":"1","article-title":"Anti-tuberculosis drug resistance pattern among pulmonary tuberculosis patients with or without HIV infection in mwanza, Tanzania","author":"Range","year":"2012","journal-title":"Tanzan J Health Res"},{"key":"10.1016\/j.ijtb.2023.01.006_bib5","first-page":"23","article-title":"Pattern of drug-resistance and treatment outcome in multidrug-resistant pulmonary tuberculosis","author":"Sbammpsc","year":"2012","journal-title":"Indian Journal of Chest Diseases & Allied Sciences"},{"issue":"9223","key":"10.1016\/j.ijtb.2023.01.006_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(00)02429-6","article-title":"Classification of drug-resistant tuberculosis in an epidemic area","volume":"356","author":"Van","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijtb.2023.01.006_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijmyco.2012.08.001","article-title":"Drug resistance-related mutations in multidrug-resistant Mycobacterium tuberculosis isolates from diverse geographical regions","volume":"1","author":"Rosales-Klintz","year":"2012","journal-title":"International Journal of Mycobacteriology"},{"issue":"5","key":"10.1016\/j.ijtb.2023.01.006_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bjid.2019.07.002","article-title":"Analysis of drug resistance mutations in pulmonary Mycobacterium tuberculosis isolates in the Southern coastal region of Andhra Pradesh, India","volume":"23","author":"Polu","year":"2019","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijtb.2023.01.006_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/e90efdb7-91c1-45f0-ae98-a88fcb407acc","article-title":"Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India","volume":"8","author":"Yadav","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijtb.2023.01.006_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09031936.00134712","article-title":"Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes","volume":"42","author":"Falzon","year":"2013","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.ijtb.2023.01.006_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133869","article-title":"A global perspective on pyrazinamide resistance: systematic review and meta-analysis","volume":"10","author":"Whitfield","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijtb.2023.01.006_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/s12879-021-06306-1","article-title":"Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China","volume":"21","author":"Che","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.ijtb.2023.01.006_bib13","doi-asserted-by":"crossref","first-page":"S619","DOI":"10.1093\/ofid\/ofx163.1637","article-title":"Correlation of specific mutations in line probe assay (LPA) and drug susceptibility test (DST) with respect to fluoroquinolone resistance in drug resistant Mycobacterium tuberculosis","volume":"4","author":"Agrawal","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijtb.2023.01.006_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/ijmy.ijmy_70_22","article-title":"Diagnostic utility of GenoType MTBDRsl assay for the detection of moxifloxacin-resistant mycobacterium tuberculosis, as compared to phenotypic method and whole-genome sequencing","volume":"11","author":"Yadav","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.ijtb.2023.01.006_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jgar.2020.11.011","article-title":"Fluroquinolone drug resistance among MDR-TB patients increases the risk of unfavourable interim microbiological treatment outcome: an observational study","volume":"24","author":"Singh","year":"2021","journal-title":"Journal of Global Antimicrobial Resistance"},{"issue":"2","key":"10.1016\/j.ijtb.2023.01.006_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/jac\/dkv360","article-title":"Specific gyrA gene mutations predict poor treatment outcome in MDR-TB","volume":"71","author":"Rigouts","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ijtb.2023.01.006_bib17","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/cix556","article-title":"Fluoroquinolone resistance mutation detection is equivalent to culture-based drug sensitivity testing for predicting multidrug-resistant tuberculosis treatment outcome: a retrospective cohort study","volume":"65","author":"R Farhat","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijtb.2023.01.006_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jiph.2019.04.009","article-title":"Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan","volume":"12","author":"Khan","year":"2019","journal-title":"Journal of Infection and Public Health"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570723000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570723000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T08:04:20Z","timestamp":1747123460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570723000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":18,"alternative-id":["S0019570723000069"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2023.01.006","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug resistance patterns and treatment outcomes in DR-TB patients at a tertiary care centre in Mumbai","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2023.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}